Giordano Rossi

9PUBLICATIONS
8CO-AUTHORS
Basic pharmacologyPsychophysiologyMolecular targetsTraditional Chinese medicine and treatmentsToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 08, 2023
Main targets of ibogaine and noribogaine associated with its putative anti-addictive effects: A mechanistic overview.

Genís Ona, Ingrid Reverte, Giordano N Rossi

|Jul 13, 2023
Multifaceted Empathy Test (MET): Validity evidence for the Brazilian population concerning the computer-based (face-to-face) and online versions.

Felipe Fernandes Vieira de Lima, Giordano Rossi, Rafael Guimarães Dos Santos

|Dec 23, 2022
Adverse Effects of Oral Cannabidiol: An Updated Systematic Review of Randomized Controlled Trials (2020-2022).

José Diogo R Souza, Julia Cozar Pacheco, Giordano Novak Rossi

|Nov 11, 2022
Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant.

Giordano Novak Rossi, Lorena T L Guerra, Glen B Baker

|Apr 15, 2022
Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges.

Giordano Novak Rossi, Jaime E C Hallak, José Carlos Bouso Saiz

|Mar 18, 2022
Ayahuasca, a potentially rapid acting antidepressant: focus on safety and tolerability.

Giordano Novak Rossi, Isabella Caroline da Silva Dias, Glen Baker

Pageof 2

Frequent Collaborators

7 joint publications

Rafael Guimarães Dos Santos

4 joint publications

José Carlos Bouso Saiz

1 joint publications

Gabriela de Oliveira Silveira

1 joint publications

Felipe Rebello Lourenço